Influenza in children: Fewer neuropsychiatric complications with oseltamivir
In 2006, the FDA warned of potential serious neuropsychiatric events in children treated with oseltamivir. A large US cohort study now paints a different picture: the risk of neurological or psychiatric complications was significantly reduced with oseltamivir.
Arzte zeitung
